Cargando…
MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
Introduction: The prevalence of hypogonadism among males is influenced by aging and obesity. The increased expression of the aromatase enzyme in the adipose tissue of obese men leads to a high conversion of androgens to estrogen, exerting a negative feedback on the hypothalamus-pituitary-gonadal axi...
Autores principales: | Colleluori, Georgia, Chen, Rui, Turin, Christie, Vigevano, Francesca, Qualls, Clifford, Mediwala, Sanjay, Villareal, Dennis, Armamento-Villareal, Reina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550839/ http://dx.doi.org/10.1210/js.2019-MON-094 |
Ejemplares similares
-
Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects
por: Colleluori, Georgia, et al.
Publicado: (2020) -
Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021) -
SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy
por: Leiter, Amanda, et al.
Publicado: (2019) -
SUN-094 Altering Cycle Duration Of A Yoyo-diet Has No Effect On Mortality In Weight Cycled Mice
por: Slyby, Julie, et al.
Publicado: (2019) -
MON-601 Obesity Pharmacotherapy Is Effective in the United States Veterans Affairs Patient Population: A Local and Virtual Cohort Study
por: Pendse, Jay, et al.
Publicado: (2020)